For many, the benefits of the medication outweigh this potential, though still uncertain, risk
Retatrutide is a triple agonist that adds glucagon, which raises energy expenditure
Kieren Mather, MD, is vice president of medical incretin and diabetes breakthroughs in the early clinical research division at Eli Lilly, where he leads efforts to develop next-generation treatments for diabetes and metabolic disorders
May Contain/Peut contenir (+/-): Titanium Dioxide (CI 77891), Iron Oxides (CI 77491, CI 77492, CI 77499), Blue 1 Lake (CI 42090), Manganese Violet (CI 77742), Yellow 5 Lake (CI 19140), Red 7 Lake (CI 15850), Red 7 (CI 15850), Red 6 (CI 15850), Carmine (CI 75470)